What do systematic reviews say?

Surgical thrombectomy vs different types of endovascular interventions

The review found no eligible studies for this question.

• Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Supplementation with folate vs no intervention, placebo or other micronutrients without folate (neonatal outcomes)

• Effects and safety of periconceptional oral folate supplementation for preventing birth defects 2015 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Active rPMS only vs no intervention

The review found no eligible studies for this question.

• Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Probiotics administered to pregnant women at risk of preterm birth vs placebo or no intervention

• Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 298 participants
  Low

Chinese herbal medicines vs no intervention

• Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Surgical thrombectomy vs mechanical thrombectomy

It is very uncertain whether surgical thrombectomy changes death compared with mechanical thrombectomy (very low certainty).

• Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts 2024 · Cochrane Headline outcomes only
  RR 1.15 [0.17, 7.99]
  1 study · 153 participants
  Very low

Mechanical thrombectomy vs pulse spray technique

It is very uncertain whether mechanical thrombectomy changes death compared with pulse spray technique (very low certainty).

• Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts 2024 · Cochrane Headline outcomes only
  RR 6.56 [0.35, 124.23]
  1 study · 120 participants
  Very low

Mechanical thrombectomy vs continuous infusion

The review found no eligible studies for this question.

• Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Surgical thrombectomy vs continuous infusion

The review found no eligible studies for this question.

• Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Continuous infusion vs pulse spray technique

The review found no eligible studies for this question.

• Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pharmacomechanical thrombolysis (Cragg® catheter) vs pulse spray technique

The review found no eligible studies for this question.

• Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Surgical thrombectomy vs pulse spray technique

The review found no eligible studies for this question.

• Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Sodium modelling vs slow dialysis

• Interventions for preventing haemodialysis dysequilibrium syndrome 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 15 participants
  Low

Summary of findings table ‐ High sodium dialysate vs standard sodium dialysate

• Interventions for preventing haemodialysis dysequilibrium syndrome 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 22 participants
  Very low

Standard interferon vs placebo or control

Standard interferon showed no clear difference in death compared with placebo or control (low certainty).

• Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
  RR 0.89 [0.06, 13.23]
  5 studies · 134 participants
  Low

High vs low dose pegylated interferon alpha‐2a or alpha‐2b

The review found no eligible studies for this question.

• Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Standard interferon plus ribavirin vs standard interferon

The review found no eligible studies for this question.

• Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pegylated interferon plus ribavirin vs pegylated interferon alone

The review found no eligible studies for this question.

• Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Direct antivirals (grazoprevir and elbasvir) vs placebo

The review found no eligible studies for this question.

• Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pegylated interferon + ribavirin (24 weeks) + initial telepravir (12 weeks) vs pegylated interferon (48 weeks) + initial telepravir (12 weeks) + initial low dose ribavirin (12 + 36 weeks)

The review found no eligible studies for this question.

• Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found